MiNK Therapeutics Inc. (INKT)

8.50

-0.45 (-5.03%)

At close: Mar 03, 2025, 3:58 PM

8.79

3.44%

After-hours: Mar 03, 2025, 03:58 PM EST

MiNK Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-22.46M	-27.99M	-30.21M	-16.24M	-23.8M
Depreciation & Amortization	204.62K	121.75K	77.96K	55.06K	36.82K
Stock-Based Compensation	3.86M	3.03M	1.74M	87.83K	219.57K
Other Working Capital	4.81M	6.11M	3.89M	-932.79K	3.23M
Other Non-Cash Items	-266.78K	-2.79M	12.18M	8.08M	4.49M
Deferred Income Tax	n/a	n/a	-355.51K	n/a	n/a
Change in Working Capital	2.9M	8.77M	3.74M	-324.93K	4.12M
Operating Cash Flow	-15.76M	-18.87M	-12.83M	-8.34M	-14.94M
Capital Expenditures	-73.56K	-250.05K	-248.98K	-95.21K	-426.47K
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-250.05M	-248.98M	n/a	n/a
Investing Cash Flow	-73.56K	-250.05K	-248.98K	-95.21K	-426.47K
Debt Repayment	n/a	n/a	9.46M	11.11M	11.44M
Common Stock Repurchased	-477.64K	-157.19K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	70.47K	1.59K	150.00	n/a	n/a
Financial Cash Flow	-407.17K	-155.6K	49.26M	11.11M	11.44M
Net Cash Flow	-16.27M	-19.25M	36.2M	2.39M	-4.06M
Free Cash Flow	-15.84M	-19.12M	-13.08M	-8.43M	-15.37M